ATE426169T1 - Fruher nachweis einer lysosomalen speicher- krankheit - Google Patents

Fruher nachweis einer lysosomalen speicher- krankheit

Info

Publication number
ATE426169T1
ATE426169T1 AT97920460T AT97920460T ATE426169T1 AT E426169 T1 ATE426169 T1 AT E426169T1 AT 97920460 T AT97920460 T AT 97920460T AT 97920460 T AT97920460 T AT 97920460T AT E426169 T1 ATE426169 T1 AT E426169T1
Authority
AT
Austria
Prior art keywords
lysosomal storage
early detection
storage disease
detection
lamp
Prior art date
Application number
AT97920460T
Other languages
English (en)
Inventor
Peter Meikle
Douglas Brooks
John Hopwood
Original Assignee
Womens & Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Womens & Childrens Hospital filed Critical Womens & Childrens Hospital
Application granted granted Critical
Publication of ATE426169T1 publication Critical patent/ATE426169T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
AT97920460T 1996-05-17 1997-05-16 Fruher nachweis einer lysosomalen speicher- krankheit ATE426169T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPN9917A AUPN991796A0 (en) 1996-05-17 1996-05-17 Early detection of lysosomal storage disorders

Publications (1)

Publication Number Publication Date
ATE426169T1 true ATE426169T1 (de) 2009-04-15

Family

ID=3794228

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97920460T ATE426169T1 (de) 1996-05-17 1997-05-16 Fruher nachweis einer lysosomalen speicher- krankheit

Country Status (10)

Country Link
US (2) US6759189B1 (de)
EP (1) EP1021725B1 (de)
JP (3) JP3837711B2 (de)
AT (1) ATE426169T1 (de)
AU (1) AUPN991796A0 (de)
CA (2) CA2253875C (de)
DE (1) DE69739317D1 (de)
IL (1) IL127033A (de)
NZ (1) NZ332641A (de)
WO (1) WO1997044668A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7090987B1 (en) 1999-04-30 2006-08-15 Nixon Ralph A Methods for the identification of compounds for the treatment of neuronal atrophy-associated dementia
WO2000067016A1 (en) * 1999-04-30 2000-11-09 The Nathan S. Kline Institute For Psychiatric Research Methods for the identification of compounds for the treatment of alzheimer's disease
EP1616193B1 (de) 2003-03-31 2012-03-21 Women's And Children's Hospital Multiplex-screening auf lysosomale speicherkrankheiten (lsds)
US7615224B2 (en) 2004-12-02 2009-11-10 Women's And Children's Hospital Multiplex-bead complex for determination of lysosomal storage disorders
ES2301280A1 (es) * 2005-05-16 2008-06-16 Fina Biotech S.L.U. Metodo para diagnosticar la enfermedad de alzheimer.
WO2007136782A2 (en) * 2006-05-19 2007-11-29 Historx, Inc. Kits and methods for evaluating misfolded proteins
EP2209890A4 (de) * 2006-12-13 2011-11-02 Tgr Biosciences Pty Ltd Förderung der ecm-produktion durch fibroblasten und/oder förderung der wanderung von fibroblasten in einem biologischen system
JP2011512876A (ja) * 2008-03-12 2011-04-28 アミカス セラピューティックス インコーポレイテッド 特異的薬理シャペロンを用いたポンペ病の治療および代理マーカーを用いた治療の監視
US8497122B2 (en) * 2008-04-11 2013-07-30 Washington University Biomarkers for Niemann-pick C disease and related disorders
GB201114909D0 (en) * 2011-08-30 2011-10-12 San Raffaele Centro Fond Biomarkers for lysosomal storage disorders
US8293487B1 (en) * 2012-01-06 2012-10-23 Jiandi Zhang Zestern, a simple, fast, specific and quantifiable improvement of immunodetection process
WO2014153083A1 (en) 2013-03-14 2014-09-25 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Compositions and methods for predicting age of onset of a lysosomal storage disease or a disease associated with a lysosomal defect
US12020820B1 (en) 2017-03-03 2024-06-25 Cerner Innovation, Inc. Predicting sphingolipidoses (fabry's disease) and decision support
US11335461B1 (en) 2017-03-06 2022-05-17 Cerner Innovation, Inc. Predicting glycogen storage diseases (Pompe disease) and decision support
US11923048B1 (en) 2017-10-03 2024-03-05 Cerner Innovation, Inc. Determining mucopolysaccharidoses and decision support tool

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859581A (en) * 1986-03-10 1989-08-22 Board Of Regents, The University Of Texas System Endoglycosidase assay
AU2990692A (en) 1991-12-06 1993-06-10 Commonwealth Scientific And Industrial Research Organisation Diagnostic method for pompe's disease
WO1994010340A1 (en) 1992-10-30 1994-05-11 Mt. Sinai Hospital Corporation Method for measuring glycosyltransferase activity

Also Published As

Publication number Publication date
EP1021725A1 (de) 2000-07-26
IL127033A (en) 2000-12-06
IL127033A0 (en) 1999-09-22
DE69739317D1 (de) 2009-04-30
EP1021725B1 (de) 2009-03-18
US20040191847A1 (en) 2004-09-30
JP4260152B2 (ja) 2009-04-30
JP3837711B2 (ja) 2006-10-25
AUPN991796A0 (en) 1996-06-13
CA2253875C (en) 2011-02-22
CA2731490A1 (en) 1997-11-27
JP2001519894A (ja) 2001-10-23
US6759189B1 (en) 2004-07-06
WO1997044668A1 (en) 1997-11-27
CA2253875A1 (en) 1997-11-27
JP2006061161A (ja) 2006-03-09
JP2008289501A (ja) 2008-12-04
EP1021725A4 (de) 2002-10-30
NZ332641A (en) 2000-05-26

Similar Documents

Publication Publication Date Title
DE69739317D1 (de) Früher nachweis einer lysosomalen speicher-krankheit
PT98710A (pt) Processo de preparacao de compostos de indolilo substituidos e de composicoes farmaceuticas que os contem
ES2172750T3 (es) Microcapsulas sensibles al ph.
BR9914044A (pt) ésteres tetrahidropirido
EP0693281A3 (de) Pharmazeutische Zubereitungen, die Fluoxetin enthalten
ES2190803T3 (es) Iminas ciclicas como pesticidas.
BR0313371A (pt) Composto, uso de um composto e método de tratamento de doença
ATE146360T1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
EP1402067A4 (de) Hs2sts als modifikatoren des p53-wegs und verwendungsverfahren
DZ3165A1 (fr) Composition alimentaire ou pharmaceutique utiliseepour prevenir ou traiter l'hyperoxalurie.
BR9713866A (pt) Composição farmacéutica
WO2003104410A3 (en) ENZYMES
BG105112A (bg) Средство с антидепресивно действие
ES2158054T3 (es) Extracto proteinico de cucumis melo con actividad antioxidante y procedimiento de preparacion, composicion cosmetica o farmaceutica o composicion alimenticia que contienen dicho extracto.
BRPI0414215A (pt) tienopirazóis
BR0200571A (pt) Produtos de legumes
TR200002248T2 (tr) Yeni dihidroksiheksanoik asit türevleri
CA2069611A1 (en) Method to Detect Bone and Other Connective Tissue Disorders in Humans and Animals
FR2809000B1 (fr) Utilisation d'ergothioneine et/ou de ses derives comme agent anti-pollution
ATE338142T1 (de) Methoden zur diagnose und behandlung von herzkrankheiten
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
DK0977871T3 (da) Neurotrypsin
PT853476E (pt) Preparacao farmaceutica que contem nimesulide para uso topico
BR0115689A (pt) Análise de expressão de inibidor de diferenciação de ácidos nucléicos e polipeptìdeos úteis na diagnose e tratamento de câncer da próstata
TR199801398T2 (xx) Ast�m� tedavi edici maddeler

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties